sb.scorecardresearch
Advertisement

Published 12:04 IST, July 4th 2020

Brazil's Anvisa approves clinical trials of China's possible COVID-19 vaccine

Brazil had already authorised the clinical trial of the vaccine ChAdOx1 nCoV-19 (AZD1222) developed by Oxford University in collaboration with AstraZeneca.

Reported by: Vishal Tiwari
Follow: Google News Icon
  • share
Brazil
null | Image: self
Advertisement

12:04 IST, July 4th 2020